posted on 2022-03-28, 16:48authored byMatthew J. Lawrence, Ahmed Sabra, Gavin Mills, Suresh Pillai, Wendy Abdullah, Karl Hawkins, Keith Morris, Simon J. Davidson, Lindsay A.Y.D’Silva, Dan Curtis, M. Rowan Brown, John W. Weisel, P. Rhodri Williams, Phillip A. Evans
This study compared patients with venous thromboembolism (VTE) to non-VTE patients using a biomarker of clot microstructure (df) and clot formation time (TGP). df was the only marker that identified a significant difference (P < 0·001) between the VTE (n = 60) and non-VTE cohorts (n = 69). The ‘abnormal’ clot microstructures in the VTE patients suggests either inadequate response to anticoagulant therapy or the presence of a procoagulant state not detected by other markers of coagulation (i.e., International Normalized Ratio). Furthermore, elevated values of df in first time VTE patients who later develop a secondary event indicates that df may identify those at risk of recurrence
Lawrence, M. J., Sabra, A., Mills, G., Pillai, S. G., Abdullah, W., Hawkins, K., Morris, R. H. K., Davidson, S. J., D'Silva, L. A., Curtis, D. J., Brown, M. R., Weisel, J. W., Williams, P. R. and Evans, P. A. (2015) 'A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolism', British Journal of Haematology, 168 (4), pp. 571–575